Clinical Trials

Inclusion Criteria:

- Women in the menopause transition or in menopause, based on clinical assessment

- PSQI score > 5, with overall sleep quality rating of "fairly bad" or "very bad".

- Motivation VAS score equal to or greater than 5 with overall motivation rating of on a
scale of 0-10 with 0 being not motivated at all and 10 being extremely motivated.

- Access to an iPad, iPhone, or android device.

- Have ability to provide informed consent.

Exclusion Criteria:

- Suspected or confirmed obstructive sleep apnea.

- Moderate to severe vasomotor symptoms warranting prescription medication use. The FDA
categories for hot flash severity are classified as mild (sensation of heat without
sweating), moderate (sensation of heat with sweating, able to continue activity), or
severe (sensation of heat with sweating cause cessation of activity).

- Use of hormone therapy or hypnotic agents.

- Use of supplements known to affect sleep.

- A known, active, untreated clinically significant psychiatric condition.

- Use of an investigational drug within 30 days of study enrollment or presence of a
known history of any condition or factor judged by the investigator to preclude
participation in the study or which might hinder adherence.

- Currently (within the past 3 weeks) been practicing mindfulness training on a
weekly/regular basis.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 2/8/2024. Questions regarding updates should be directed to the study team contact.